Indoco Remedies Limited has submitted a regulatory filing to the National Stock Exchange of India Limited and Bombay Stock Exchange Limited regarding the availability of their earnings conference call recording.
The disclosure is made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The earnings conference call was conducted today, 27th October 2026, specifically addressing the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September, 2026.
The call commenced at 03:00 PM Indian Standard Time (IST) and concluded at 04:05 PM IST on the same date.
The audio recording of this earnings conference call is now available on the company's official website at https://www.indoco.com/inv-fin-concall-transcripts.asp.
The communication was digitally signed by Ramanathan Hariharan, who holds the positions of Company Secretary & Head-Legal at Indoco Remedies Limited, on 27th October 2026 at 16:36:12 IST.
The company has requested both stock exchanges to take this disclosure on official record.